Canopy Growth Posts Q4 EPS of -$0.29 and $51.3M Revenue; Debt/Equity 0.34
CGC•Canopy Growth reported Q4 EPS of -$0.29 and revenue of $51.32 million, both below estimates. Revenue rose from $45.3 million a year ago and grew 10% in Canada Medical and 68% internationally while maintaining a debt-to-equity ratio of 0.34 and a current ratio of 5.34.
1. Q4 Financial Results
Canopy Growth recorded fiscal Q4 EPS of -$0.29, missing estimates by $0.23, and reported revenue of $51.32 million, falling short of the $53.43 million forecasts. The adjusted loss narrowed 71% from a year earlier, reflecting reduced operational expenses.
2. Year-over-Year Improvements
Revenue climbed from $45.3 million in the prior-year quarter, driven by a 10% increase in the Canada Medical segment and a 68% surge in International Markets cannabis sales. The quarterly loss also improved from -$0.94 per share a year ago.
3. Strategic Restructuring and Acquisitions
The company has accelerated cost-reduction measures and expanded through the acquisition of MTL Cannabis to streamline operations and access new markets. Management expects these moves to underpin top-line growth and profitability over the coming quarters.
4. Balance Sheet and Liquidity
Canopy Growth maintains a conservative financial position with a debt-to-equity ratio of 0.34 and a current ratio of 5.34, indicating ample short-term liquidity. The negative price-to-earnings ratio of -1.39 reflects ongoing unprofitability but follows improving operating metrics.
